OPT 6.49% 41.0¢ opthea limited

Ann: Opthea Completes Placement & Institutional Entitlement Offer, page-32

  1. 7 Posts.
    lightbulb Created with Sketch. 3
    If there is clinical success the SP will go way above $1. I wouldn't be stuffed full of 80c options if I thought that. Pfizer sell US$10b of Eylea peryear and sozinibercept combo will eclipse all comers. Why woudln't Pfizer pay OPT US$1b per year to add a sozinibercept to each treatment and stay ahead of the pack? Do the math on US$1b per year profit. At PE of 10 that US$10b = $16? Not saying that will happen but there's the ball park.
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
41.0¢
Change
0.025(6.49%)
Mkt cap ! $492.4M
Open High Low Value Volume
39.0¢ 41.0¢ 38.5¢ $430.2K 1.078M

Buyers (Bids)

No. Vol. Price($)
26 66868 40.5¢
 

Sellers (Offers)

Price($) Vol. No.
41.0¢ 146958 10
View Market Depth
Last trade - 15.08pm 24/07/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.